Doctor Theiss Rinotheiss Sea water (Spray) Instructions for Use
ATC Code
R01AX10 (Other drugs)
Active Substance
Sea water
Clinical-Pharmacological Group
Drug for moisturizing, cleansing, and protecting the nasal mucosa
Pharmacotherapeutic Group
Remedy for nasal conditions
Pharmacological Action
A product for intranasal use. It helps maintain the normal physiological state of the nasal mucosa.
It helps to thin mucus and facilitates its removal from the nose. The microelements contained in sea water improve the function of the ciliated epithelium, which enhances the resistance of the nasal mucosa to pathogenic bacteria and viruses. In allergic rhinitis, it helps remove allergens from the nasal mucosa.
Indications
- Acute and chronic inflammatory diseases of the nose, paranasal sinuses, and nasopharynx.
- Prevention of infectious diseases of the nose and nasopharynx.
- Allergic and vasomotor rhinitis.
- Prevention of inflammatory processes after surgical interventions.
- Daily hygiene of the nasal cavity to preserve the protective properties of the mucosa under conditions of increased air dryness or pollution.
ICD codes
| ICD-10 code | Indication |
| J00 | Acute nasopharyngitis (common cold) |
| J01 | Acute sinusitis |
| J06.9 | Acute upper respiratory infection, unspecified |
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.3 | Other allergic rhinitis (perennial allergic rhinitis) |
| J31.0 | Chronic rhinitis (including ozaena, atrophic and hypertrophic rhinitis) |
| J31.1 | Chronic nasopharyngitis |
| J32 | Chronic sinusitis |
| Z54.0 | Convalescence following surgery |
| ICD-11 code | Indication |
| CA00 | Acute nasopharyngitis |
| CA01 | Acute rhinosinusitis |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
| CA08.00 | Allergic rhinitis due to pollen |
| CA08.03 | Other allergic rhinitis |
| CA08.3 | Vasomotor rhinitis |
| CA09.0 | Chronic rhinitis |
| CA09.1 | Chronic nasopharyngitis |
| CA0A.Z | Chronic rhinosinusitis, unspecified |
| QB7Y | Other specified convalescence |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer the spray intranasally. For therapeutic purposes, use 4-6 times per day.
For daily hygienic purposes, use 1-4 times per day.
In children, start from 2 weeks of age using the appropriate pediatric dosage form. Apply the same frequency as in adults.
Adverse Reactions
Allergic reactions are possible. Discontinue use immediately if signs of hypersensitivity, such as local irritation or rash, appear.
Report any persistent or severe adverse reactions to a healthcare professional.
Contraindications
- Do not use in children under 2 weeks of age due to lack of safety data.
- Contraindicated in patients with a known hypersensitivity to any component of the formulation.
Use in Pregnancy and Lactation
Can be used during pregnancy and breastfeeding as indicated.
Pediatric Use
Data on use in children under 2 weeks of age are not available.
In children over 2 weeks of age, it is used in the appropriate dosage form.
Geriatric Use
The drug is approved for use in elderly patients.
Special Precautions
Consultation with a doctor is required if use is necessary after surgery.
Drug Interactions
No clinically significant drug interactions have been identified. Can be used concomitantly with other intranasal medications.
Maintain a time interval of several minutes between applications if using other nasal sprays to avoid dilution of the active substance.
Overdose
Overdose is unlikely due to the local application and nature of the product. No specific antidote is required.
In case of accidental ingestion of a large volume, symptomatic and supportive care is recommended.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Nasal spray: bottle 20 ml.
Marketing Authorization Holder
Dr. Theiss Naturwaren GmbH (Germany)
Dosage Form
| Doctor Theiss Rinotheiss Sea water | Nasal spray: bottle 20 ml. |
Dosage Form, Packaging, and Composition
| Nasal spray | 1 bottle |
| Sea water | 20 ml |
20 ml – dark glass bottle (1) with a spray cap – cardboard packs.
Nasal spray: bottle 30 ml.
Marketing Authorization Holder
Dr. Theiss Naturwaren GmbH (Germany)
Dosage Form
| Doctor Theiss Rinotheiss Sea water | Nasal spray: bottle 30 ml. |
Dosage Form, Packaging, and Composition
| Nasal spray | 1 bottle |
| Sea water | 30 ml |
30 ml – dark glass bottle (1) with a spray cap – cardboard packs.
No-spa pills 40mg, 64pcs 